LUCD – lucid diagnostics inc. (US:NASDAQ)
Stock Stats
News
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Lucid Diagnostics (LUCD) had its "buy" rating reaffirmed by BTIG Research. They now have a $2.50 price target on the stock.
Lucid Diagnostics (LUCD) was upgraded by Wall Street Zen from "sell"
Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Lucid Diagnostics (LUCD) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $3.00 price target on the stock.
Form EFFECT Lucid Diagnostics Inc.
Form 424B5 Lucid Diagnostics Inc.
Form 8-K Lucid Diagnostics Inc. For: Mar 26
Form S-3/A Lucid Diagnostics Inc.
Form 10-K Lucid Diagnostics Inc. For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.